These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31771386)

  • 1. Neuroprotective effects of mitoquinone and oleandrin on Parkinson's disease model in zebrafish.
    Ünal İ; Çalışkan-Ak E; Üstündağ ÜV; Ateş PS; Alturfan AA; Altinoz MA; Elmaci I; Emekli-Alturfan E
    Int J Neurosci; 2020 Jun; 130(6):574-582. PubMed ID: 31771386
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of molecular network of gut-brain axis associated with neuroprotective effects of PPARδ-ligand erucic acid in rotenone-induced Parkinson's disease model in zebrafish.
    Ünal İ; Cansız D; Sürmen MG; Sürmen S; Sezer Z; Beler M; Üstündağ ÜV; Güzel E; Alturfan AA; Emekli-Alturfan E
    Eur J Neurosci; 2023 Feb; 57(4):585-606. PubMed ID: 36564343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monascin exhibits neuroprotective effects in rotenone model of Parkinson's disease via antioxidation and anti-neuroinflammation.
    Lin Q; Hou S; Dai Y; Jiang N; Lin Y
    Neuroreport; 2020 Jun; 31(9):637-643. PubMed ID: 32427711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
    Avcı B; Günaydın C; Güvenç T; Yavuz CK; Kuruca N; Bilge SS
    Neurochem Res; 2021 Mar; 46(3):513-522. PubMed ID: 33247801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson's disease.
    Palle S; Neerati P
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):445-453. PubMed ID: 29411055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function.
    Serrano-García N; Fernández-Valverde F; Luis-Garcia ER; Granados-Rojas L; Juárez-Zepeda TE; Orozco-Suárez SA; Pedraza-Chaverri J; Orozco-Ibarra M; Jiménez-Anguiano A
    Neurochem Int; 2018 Dec; 121():26-37. PubMed ID: 30342962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Pyridinylboronic Acid Ameliorates Rotenone-Induced Oxidative Stress Through Nrf2 Target Genes in Zebrafish Embryos.
    Üstündağ FD; Ünal İ; Üstündağ ÜV; Cansız D; Beler M; Karagöz A; Kara Subaşat H; Alturfan AA; Mega Tiber P; Emekli-Alturfan E
    Neurochem Res; 2022 Jun; 47(6):1553-1564. PubMed ID: 35142995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
    Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
    Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis.
    Zhang X; Du L; Zhang W; Yang Y; Zhou Q; Du G
    Sci Rep; 2017 Aug; 7(1):9968. PubMed ID: 28855526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effects of Eexenatide in a Rotenone-Induced Rat Model of Parkinson's Disease.
    Aksoy D; Solmaz V; Çavuşoğlu T; Meral A; Ateş U; Erbaş O
    Am J Med Sci; 2017 Sep; 354(3):319-324. PubMed ID: 28918840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary optimization of a Chinese herbal medicine formula based on the neuroprotective effects in a rat model of rotenone-induced Parkinson's disease.
    Bao XX; Ma HH; Ding H; Li WW; Zhu M
    J Integr Med; 2018 Jul; 16(4):290-296. PubMed ID: 29866613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish.
    Wang Y; Liu W; Yang J; Wang F; Sima Y; Zhong ZM; Wang H; Hu LF; Liu CF
    Neurotoxicology; 2017 Jan; 58():103-109. PubMed ID: 27866991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Possible Role of
    Ilie OD; Paduraru E; Robea MA; Balmus IM; Jijie R; Nicoara M; Ciobica A; Nita IB; Dobrin R; Doroftei B
    Oxid Med Cell Longev; 2021; 2021():9629102. PubMed ID: 34691361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-targeted therapy rescues development and quality of embryos derived from oocytes matured under oxidative stress conditions: a bovine in vitro model.
    Marei WFA; Van den Bosch L; Pintelon I; Mohey-Elsaeed O; Bols PEJ; Leroy JLMR
    Hum Reprod; 2019 Oct; 34(10):1984-1998. PubMed ID: 31625574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
    Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
    J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Kang SY; Lee SB; Kim HJ; Kim HT; Yang HO; Jang W
    Neurosci Lett; 2017 Mar; 642():20-26. PubMed ID: 28137648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson's disease.
    Khatri DK; Juvekar AR
    Pharmacol Biochem Behav; 2016; 150-151():39-47. PubMed ID: 27619637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.